Host Factors Required for Dengue and Yellow Fever Virus Amplification
登革热和黄热病病毒扩增所需的宿主因素
基本信息
- 批准号:8391158
- 负责人:
- 金额:$ 21.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-03 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenovirusesAffectAntiviral AgentsBindingBinding SitesBiochemicalBiological AssayCell Culture TechniquesCellsComplexCytolysisDataDefectDengueDengue VirusDevelopmentDrug resistanceEvolutionGeneticGoalsGrowthHerpesvirus 1HumanHuman poliovirusIn VitroInfectionInfection ControlIntegration Host FactorsKnowledgeLabelLifeLife Cycle StagesMapsMass Spectrum AnalysisMetabolicMethodsMutationNaturePathway AnalysisPathway interactionsPhasePoliovirusesPolymeraseProcessProtein BindingProteinsProteomicsRNARNA SequencesRNA VirusesReporterResistanceResistance developmentReverse Transcriptase Polymerase Chain ReactionRoleSpecificitySucroseTherapeuticThiouracilTimeToxic effectTranslationsViralViral Hemorrhagic FeversViral PathogenesisViral ProteinsVirusVirus DiseasesYellow FeverYellow Fever Virus InfectionYellow fever virusbasecomparativecrosslinkdensitydrug resistant virushigh throughput screeninginhibitor/antagonistlink proteinmutantpathogenpressurepreventprotein protein interactionresponsestable isotopeviral RNAvirus host interaction
项目摘要
DESCRIPTION (provided by applicant):
Dengue and yellow fever virus are significant human pathogens that cause hemorrhagic fever and fatalities. Currently, there are no approved antivirals for these viruses. The development of antivirals for RNA viruses has proven to be particularly difficult due to the rapid emergence of drug resistant viruses. This is primarily due to the error prone nature of the polymerase, which results in rapid evolution of the virus under selective pressure. Targeting a host factor for which
the virus does not have any genetic control over should decrease or prevent development of resistant mutants either because the virus cannot function without the host factor or because more mutations are required to confer resistance. Towards this goal we have developed a robust method to identify host factors that are bound to the viral RNA during viral amplification i cell culture. We will use this method to identify host factors that are bound to the dengue virus and yellow fever virus RNA. We will identify which host factors will be good targets to develop antiviral targets. In addition, we will also determine the step in the viral life cycle the host fators participate in and the protein-protein and protein-viral RNA interactions for that host factor during viral infection. These studies will address the mechanism of the host factor in viral amplification and enable development of a high-throughput assay fro inhibitors of the host factor.
PUBLIC HEALTH RELEVANCE:
RNA viruses rapidly evolve resistant viruses to antiviral that target the viral proteins. An antivial that targets a host protein would significantly reduce or prevent drug resistance. Therefore, we will identify host factors that interact with dengue and yellow fever viral RNAs and determine their role in the viral life cycle in order to identify an effective antiviral target.
描述(由申请人提供):
登革热和黄热病病毒是引起出血热和死亡的重要人类病原体。目前,还没有针对这些病毒的批准的抗病毒药物。由于耐药病毒的快速出现,RNA病毒的抗病毒药物的开发已被证明是特别困难的。这主要是由于聚合酶的易错性,这导致病毒在选择压力下快速进化。针对宿主因子,
病毒没有任何遗传控制,应该减少或防止抗性突变体的发展,因为病毒没有宿主因子就不能发挥作用,或者因为需要更多的突变来赋予抗性。为了实现这一目标,我们已经开发了一种稳健的方法来鉴定在细胞培养中病毒扩增期间与病毒RNA结合的宿主因子。我们将使用这种方法来鉴定与登革热病毒和黄热病毒RNA结合的宿主因子。我们将确定哪些宿主因子将是开发抗病毒靶点的良好靶点。此外,我们还将确定宿主因子参与病毒生命周期的步骤,以及病毒感染期间该宿主因子的蛋白质-蛋白质和蛋白质-病毒RNA相互作用。这些研究将解决宿主因子在病毒扩增中的机制,并能够开发宿主因子抑制剂的高通量检测方法。
公共卫生相关性:
RNA病毒迅速进化出对靶向病毒蛋白的抗病毒药物具有抗性的病毒。靶向宿主蛋白质的抗病毒药物将显著降低或防止耐药性。因此,我们将确定与登革热和黄热病病毒RNA相互作用的宿主因子,并确定它们在病毒生命周期中的作用,以确定有效的抗病毒靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ileana M. Cristea其他文献
The protein composition of human adenovirus replication compartments
人腺病毒复制区室的蛋白质组成
- DOI:
10.1128/mbio.02144-24 - 发表时间:
2024-11-29 - 期刊:
- 影响因子:4.700
- 作者:
Paloma Hidalgo;Amada Torres;Pierre M. Jean Beltran;Gamaliel López-Leal;Luca D. Bertzbach;Thomas Dobner;S. J. Flint;Ileana M. Cristea;Ramón A. González - 通讯作者:
Ramón A. González
Fpa (YlaN) is an iron(II) binding protein that functions to relieve Fur-mediated repression of gene expression in emStaphylococcus aureus/em
Fpa(YlaN)是一种铁(II)结合蛋白,其作用是缓解金黄色葡萄球菌中 Fur 介导的基因表达抑制。
- DOI:
10.1128/mbio.02310-24 - 发表时间:
2024-10-09 - 期刊:
- 影响因子:4.700
- 作者:
Jeffrey M. Boyd;Kylie Ryan Kaler;Karla Esquilín-Lebrón;Ashley Pall;Courtney J. Campbell;Mary E. Foley;Gustavo Rios-Delgado;Emilee M. Mustor;Timothy G. Stephens;Hannah Bovermann;Todd M. Greco;Ileana M. Cristea;Valerie J. Carabetta;William N. Beavers;Debashish Bhattacharya;Eric P. Skaar;Lindsey N. Shaw;Timothy L. Stemmler - 通讯作者:
Timothy L. Stemmler
emIn vitro/em and emex vivo/em proteomics of emMycobacterium marinum/em biofilms and the development of biofilm-binding synthetic nanobodies
海分枝杆菌生物膜的体外和体内蛋白质组学以及生物膜结合合成纳米抗体的开发
- DOI:
10.1128/msystems.01073-22 - 发表时间:
2023-05-03 - 期刊:
- 影响因子:4.600
- 作者:
Milka Marjut Hammarén;Hanna Luukinen;Alina Sillanpää;Kim Remans;Karine Lapouge;Tânia Custódio;Christian Löw;Henna Myllymäki;Toni Montonen;Markus Seeger;Joseph Robertson;Tuula A. Nyman;Kirsi Savijoki;Mataleena Parikka;Ileana M. Cristea;Paul Cos - 通讯作者:
Paul Cos
Liquid–liquid phase separation in innate immunity
天然免疫中的液-液相分离
- DOI:
10.1016/j.it.2024.04.009 - 发表时间:
2024-06-01 - 期刊:
- 影响因子:13.900
- 作者:
Dawei Liu;Jinhang Yang;Ileana M. Cristea - 通讯作者:
Ileana M. Cristea
A Primer on Proteomic Characterization of Intercellular Communication in a Virus Microenvironment
病毒微环境中细胞间通讯的蛋白质组学表征入门
- DOI:
10.1016/j.mcpro.2025.100913 - 发表时间:
2025-03-01 - 期刊:
- 影响因子:5.500
- 作者:
James C. Kostas;Colter S. Brainard;Ileana M. Cristea - 通讯作者:
Ileana M. Cristea
Ileana M. Cristea的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ileana M. Cristea', 18)}}的其他基金
Methods and Logic in Molecular Biology Training Program
分子生物学方法与逻辑培训计划
- 批准号:
10721701 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
Dynamic virus-driven remodeling of ER-mitochondria contacts
内质网-线粒体接触的动态病毒驱动重塑
- 批准号:
10707412 - 财政年份:2022
- 资助金额:
$ 21.96万 - 项目类别:
Dynamic virus-driven remodeling of ER-mitochondria contacts
内质网-线粒体接触的动态病毒驱动重塑
- 批准号:
10608035 - 财政年份:2022
- 资助金额:
$ 21.96万 - 项目类别:
Mechanisms mediating immune response upon sensing of nuclear viral DNA
感测核病毒 DNA 介导免疫反应的机制
- 批准号:
10266082 - 财政年份:2015
- 资助金额:
$ 21.96万 - 项目类别:
Mechanisms mediating immune response upon sensing of nuclear viral DNA
感测核病毒 DNA 介导免疫反应的机制
- 批准号:
9027921 - 财政年份:2015
- 资助金额:
$ 21.96万 - 项目类别:
Mechanisms mediating immune response upon sensing of nuclear viral DNA
感测核病毒 DNA 介导免疫反应的机制
- 批准号:
9973554 - 财政年份:2015
- 资助金额:
$ 21.96万 - 项目类别:
Mechanisms mediating immune response upon sensing of nuclear viral DNA
感测核病毒 DNA 介导免疫反应的机制
- 批准号:
10456254 - 财政年份:2015
- 资助金额:
$ 21.96万 - 项目类别:
Mechanisms mediating immune response upon sensing of nuclear viral DNA
感测核病毒 DNA 介导免疫反应的机制
- 批准号:
10672215 - 财政年份:2015
- 资助金额:
$ 21.96万 - 项目类别:
Host Factors Required for Dengue and Yellow Fever Virus Amplification
登革热和黄热病病毒扩增所需的宿主因素
- 批准号:
8522155 - 财政年份:2012
- 资助金额:
$ 21.96万 - 项目类别:
Proteomic Tools to Uncover the Role of Chromatin Remodeling in HIV-1 Infection
揭示染色质重塑在 HIV-1 感染中作用的蛋白质组学工具
- 批准号:
8117154 - 财政年份:2008
- 资助金额:
$ 21.96万 - 项目类别:
相似海外基金
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
- 批准号:
10436626 - 财政年份:2021
- 资助金额:
$ 21.96万 - 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10557162 - 财政年份:2021
- 资助金额:
$ 21.96万 - 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
- 批准号:
21K08199 - 财政年份:2021
- 资助金额:
$ 21.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10330464 - 财政年份:2021
- 资助金额:
$ 21.96万 - 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
- 批准号:
9807741 - 财政年份:2019
- 资助金额:
$ 21.96万 - 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2018
- 资助金额:
$ 21.96万 - 项目类别:
Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
- 批准号:
18K15937 - 财政年份:2018
- 资助金额:
$ 21.96万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2017
- 资助金额:
$ 21.96万 - 项目类别:
Discovery Grants Program - Individual
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
- 批准号:
16K09118 - 财政年份:2016
- 资助金额:
$ 21.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
- 批准号:
1813152 - 财政年份:2016
- 资助金额:
$ 21.96万 - 项目类别:
Studentship